HRP20120422T1 - Farmaceutski pripravak koji sadrži stefaglabrin sulfat za liječenje demijelinizirajućih bolesti živčanog sustava i za unaprjeđivanje procesa obnavljanja mijelinske ovojnice živčanih vlakana - Google Patents
Farmaceutski pripravak koji sadrži stefaglabrin sulfat za liječenje demijelinizirajućih bolesti živčanog sustava i za unaprjeđivanje procesa obnavljanja mijelinske ovojnice živčanih vlakana Download PDFInfo
- Publication number
- HRP20120422T1 HRP20120422T1 HRP20120422AT HRP20120422T HRP20120422T1 HR P20120422 T1 HRP20120422 T1 HR P20120422T1 HR P20120422A T HRP20120422A T HR P20120422AT HR P20120422 T HRP20120422 T HR P20120422T HR P20120422 T1 HRP20120422 T1 HR P20120422T1
- Authority
- HR
- Croatia
- Prior art keywords
- nervous system
- demyelinating diseases
- nerve fibers
- myelin sheath
- pharmaceutical preparation
- Prior art date
Links
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 title claims abstract 7
- 208000016192 Demyelinating disease Diseases 0.000 title claims abstract 5
- 210000000653 nervous system Anatomy 0.000 title claims abstract 5
- 210000003007 myelin sheath Anatomy 0.000 title claims abstract 4
- 210000004126 nerve fiber Anatomy 0.000 title claims abstract 4
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 230000001737 promoting effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 1
- 238000002636 symptomatic treatment Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
Farmaceutski lijek za primjenu u liječenju demijelinizirajućih bolesti živčanog sustava, naznačen time da stefaglabrin sulfat koji je u njemu sadržan doprinosi obnavljanju mijelinske ovojnice živčanih vlakana. Patent sadrži još 4 patentna zahtjeva.
Claims (5)
1. Farmaceutski lijek za primjenu u liječenju demijelinizirajućih bolesti živčanog sustava, naznačen time da stefaglabrin sulfat koji je u njemu sadržan doprinosi obnavljanju mijelinske ovojnice živčanih vlakana.
2. Farmaceutski lijek iz Zahtjeva 1, naznačen time da sadržaj stefaglabrin sulfata varira između 0,2% i 1,0%.
3. Primjena stefaglabrin sulfata u proizvodnji lijeka naznačena time da doprinosi obnavljanju mijelinske ovojnice živčanih vlakana.
4. 0,25%-tna otopina stefaglabrin sulfata za primjenu u liječenju demijelinizirajućih bolesti živčanog sustava, uključujući simptomatsko liječenje i elektrofiziološke postupke, naznačena time da se navedena otopina primjenjuje parenteralno.
5. Otopina iz Zahtjeva 4, naznačena time da se stefaglabrin sulfat primjenjuje u dozi od 2 – 8 ml dvaput dnevno.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2007145037/15A RU2355413C1 (ru) | 2007-12-06 | 2007-12-06 | Фармацевтическое средство для лечения демиелинизирующих заболеваний нервной системы, средство, способствующее восстановлению миелиновой оболочки нервного волокна, и способ лечения демиелинизирующих заболеваний нервной системы |
| PCT/RU2008/000747 WO2009075607A2 (en) | 2007-12-06 | 2008-12-05 | Pharmaceutical preparation for treating demyelinating diseases of the nervous system; preparation promoting restoration of the myelin sheath of nerve fibers; and a method for treating demyelinating diseases of the nervous system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20120422T1 true HRP20120422T1 (hr) | 2012-06-30 |
Family
ID=40756011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20120422AT HRP20120422T1 (hr) | 2007-12-06 | 2012-05-16 | Farmaceutski pripravak koji sadrži stefaglabrin sulfat za liječenje demijelinizirajućih bolesti živčanog sustava i za unaprjeđivanje procesa obnavljanja mijelinske ovojnice živčanih vlakana |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8440683B2 (hr) |
| EP (1) | EP2271340B1 (hr) |
| JP (1) | JP5485166B2 (hr) |
| KR (1) | KR20100113505A (hr) |
| CN (1) | CN101888842B (hr) |
| AT (1) | ATE552001T1 (hr) |
| CA (1) | CA2707681C (hr) |
| CY (1) | CY1112818T1 (hr) |
| DK (1) | DK2271340T3 (hr) |
| EA (1) | EA201000786A1 (hr) |
| ES (1) | ES2383315T3 (hr) |
| HR (1) | HRP20120422T1 (hr) |
| PL (1) | PL2271340T3 (hr) |
| PT (1) | PT2271340E (hr) |
| RU (1) | RU2355413C1 (hr) |
| SI (1) | SI2271340T1 (hr) |
| UA (1) | UA97875C2 (hr) |
| WO (1) | WO2009075607A2 (hr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102526648B1 (ko) | 2015-08-21 | 2023-04-27 | 삼성전자주식회사 | 2,5-디히드록시벤젠술폰산을 포함하는 신경세포의 수초화를 촉진하기 위한 조성물 및 그의 용도 |
| RU2020126425A (ru) | 2018-01-11 | 2022-02-11 | М Эт П Фарма Аг | Лечение демиелинизирующих заболеваний |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU1713151C (ru) | 1986-07-05 | 1995-02-09 | Научно-производственное объединение "ВНИИ лекарственных и ароматических растений" | Средство для лечения травматических и послеоперационных повреждений периферической нервной системы |
| RU2089610C1 (ru) | 1994-03-29 | 1997-09-10 | Институт физиологии растений им.К.А.Тимирязева РАН | Штамм культивируемых клеток растенийй stephania glabra (roxb) miers - продуцент стефарина |
| AU2002246619A1 (en) | 2000-12-08 | 2003-06-23 | Neuronz Limited | Use of insuline-like growth factor-i for promoting remyelination of axons |
| AU2002363800A1 (en) * | 2001-11-13 | 2003-05-26 | Loi Tran | Therapeutic agent composition and method of use |
-
2007
- 2007-12-06 RU RU2007145037/15A patent/RU2355413C1/ru not_active IP Right Cessation
-
2008
- 2008-12-05 WO PCT/RU2008/000747 patent/WO2009075607A2/en active Application Filing
- 2008-12-05 DK DK08859308.2T patent/DK2271340T3/da active
- 2008-12-05 JP JP2010536875A patent/JP5485166B2/ja not_active Expired - Fee Related
- 2008-12-05 AT AT08859308T patent/ATE552001T1/de active
- 2008-12-05 US US12/734,947 patent/US8440683B2/en not_active Expired - Fee Related
- 2008-12-05 KR KR1020107014826A patent/KR20100113505A/ko active IP Right Grant
- 2008-12-05 CA CA2707681A patent/CA2707681C/en not_active Expired - Fee Related
- 2008-12-05 EA EA201000786A patent/EA201000786A1/ru unknown
- 2008-12-05 PL PL08859308T patent/PL2271340T3/pl unknown
- 2008-12-05 CN CN2008801196290A patent/CN101888842B/zh not_active Expired - Fee Related
- 2008-12-05 ES ES08859308T patent/ES2383315T3/es active Active
- 2008-12-05 UA UAA201008255A patent/UA97875C2/ru unknown
- 2008-12-05 SI SI200830658T patent/SI2271340T1/sl unknown
- 2008-12-05 PT PT08859308T patent/PT2271340E/pt unknown
- 2008-12-05 EP EP08859308A patent/EP2271340B1/en not_active Not-in-force
-
2012
- 2012-05-16 HR HRP20120422AT patent/HRP20120422T1/hr unknown
- 2012-06-06 CY CY20121100506T patent/CY1112818T1/el unknown
-
2013
- 2013-04-11 US US13/861,012 patent/US20130226133A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20100267756A1 (en) | 2010-10-21 |
| PT2271340E (pt) | 2012-06-01 |
| ES2383315T3 (es) | 2012-06-20 |
| CA2707681A1 (en) | 2009-06-18 |
| EP2271340B1 (en) | 2012-04-04 |
| EA201000786A1 (ru) | 2010-12-30 |
| KR20100113505A (ko) | 2010-10-21 |
| SI2271340T1 (sl) | 2012-07-31 |
| CY1112818T1 (el) | 2016-02-10 |
| DK2271340T3 (da) | 2012-06-11 |
| PL2271340T3 (pl) | 2012-09-28 |
| CN101888842B (zh) | 2012-07-04 |
| EP2271340A2 (en) | 2011-01-12 |
| CN101888842A (zh) | 2010-11-17 |
| JP2011506316A (ja) | 2011-03-03 |
| RU2355413C1 (ru) | 2009-05-20 |
| WO2009075607A2 (en) | 2009-06-18 |
| ATE552001T1 (de) | 2012-04-15 |
| US20130226133A1 (en) | 2013-08-29 |
| CA2707681C (en) | 2013-01-08 |
| UA97875C2 (ru) | 2012-03-26 |
| US8440683B2 (en) | 2013-05-14 |
| JP5485166B2 (ja) | 2014-05-07 |
| WO2009075607A3 (en) | 2009-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201200002A1 (ru) | Производные индоламида и родственные соединения для использования при лечении нейродегенеративных заболеваний | |
| MX2011007854A (es) | Metodos para tratar infartos agudos al miocardio y trastornos relacionados. | |
| EA201690069A1 (ru) | Применение высоких доз придопидина для лечения болезни хантингтона | |
| EA201071244A1 (ru) | Новые терапевтические подходы в лечении болезни альцгеймера и обусловленных ею расстройств посредством модуляции ангиогенеза | |
| MX2010004614A (es) | Composiciones para tratamiento del mal de parkinson. | |
| BR112012010470A2 (pt) | novas abordagens terapêuticas para o tratamento da doença de alzheimer | |
| NZ599830A (en) | Novel kinase modulators | |
| NZ589807A (en) | Method for preventing and treating neurodegenerative diseases using a grape seed extract having less than 12% by weight galloylated proanthocyanidins | |
| EA201491460A1 (ru) | ПРИМЕНЕНИЕ ЛАХИНИМОДА В ЛЕЧЕНИИ ПАЦИЕНТОВ С БОЛЕЗНЬЮ КРОНА, У КОТОРЫХ НЕ ЭФФЕКТИВНА ТЕРАПИЯ ПЕРВОЙ ЛИНИИ АНТИ-TNFα | |
| HRP20140784T1 (hr) | Glyx-13 za uporabu u postupku tretiranja refraktornih depresija | |
| EA201000365A1 (ru) | Гетероциклические амиды, пригодные для лечения злокачественного новообразования и псориаза | |
| EA201590654A1 (ru) | Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона | |
| EA201590697A1 (ru) | Производные кетамина | |
| EA201171088A1 (ru) | Лечение дискинезии при различных расстройствах | |
| NZ600544A (en) | Compositions and methods for the treatment of angiogenesis-related eye diseases | |
| EA201590933A1 (ru) | Новые перорально биодоступные соединения, модулирующие контроль дыхания, и способы их использования | |
| ATE353645T1 (de) | Verwendung von 2-oxo-1-pyrrolidin-derivaten zur herstellung eines arzneimittels zur behandlung von dyskinesia | |
| EA201491427A1 (ru) | Замещенные фенилимидазопиразолы и их применение | |
| EA036542B9 (ru) | Галоген-замещенные пиперидины в качестве модуляторов орексинового рецептора | |
| WO2018005794A3 (en) | Novel non-systemic tgr5 agonists | |
| WO2011027363A3 (en) | Method of treatment of neurodegenerative or neuro-muscular degenerative diseases and therapeutic agent to treat the same | |
| MX2010006608A (es) | Composiciones farmaceuticas y produccion y uso de las mismas en el tratamiento de neuropatias asociadas con el dolor. | |
| WO2009003694A3 (en) | Method for treating diseases related to mitochondrial dysfunction | |
| MX2009007889A (es) | Derivados de 3-cinnolincarboxamida y su uso para el tratamiento del cancer. | |
| HRP20120422T1 (hr) | Farmaceutski pripravak koji sadrži stefaglabrin sulfat za liječenje demijelinizirajućih bolesti živčanog sustava i za unaprjeđivanje procesa obnavljanja mijelinske ovojnice živčanih vlakana |